Cyclerion Therapeutics Inc (CYCN) Stock Price, Quote & News

Company Profile

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebi...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 327 8778

Website: www.cyclerion.com

Address:

245 First Street, Riverview II, 18th Floor, Cambridge, United States

BiotechValues Sep. 9 at 4:17 PM

$CYCN Remember, the stock will close red on any news day. I'm convinced of this, with the incredible dilution coming, years to the next data catalyst, and terrible mgmt. Any pop on news will be immediately sold off and go deep red. I only trade the stock to take advantage of the idiots here

0 · Reply

SDBiotechInvestor Sep. 9 at 4:16 PM

$CYCN - too funny and embarrassing. Joel dumped $CYCN over the past week down to $2.10 only to REBUY the shares the next day after posting this.

0 · Reply

SDBiotechInvestor Sep. 9 at 4:12 PM

$CYCN outperforming all biotechs on my watchlist today. Long 35k shares :)

1 · Reply

BiotechValues Sep. 9 at 4:01 PM

$CYCN I discussed opportunity cost here and let's give some examples. Thank GOD I loaded a bunch of these over the past 30 days: CYCN flat/negative for the past month, PEPG 60% gains last month, BCAB 78% gains past month, PYXS 76% gains past month, ARCT 54% gains pat month. etc

1 · Reply

skyrockets_Inc Sep. 9 at 2:50 PM

$CYCN i made a hero trade yesterday, sold all of my $GLTO at $5 on that pump. Time to buy more $CYCN

0 · Reply

SDBiotechInvestor Sep. 9 at 1:31 PM

$CYCN - Going on a one-week trip starting tomorrow. If the universe plays out like it did for $GLTO (I was on a trip when they PR last year), we get a PR between September 10-17.

1 · Reply

skyrockets_Inc Sep. 8 at 8:05 PM

$CYCN All those scare tactics in the morning to drop it and then we end up closing green lol

1 · Reply

AshleySchaeffer_BMW Sep. 8 at 5:31 PM

$CYCN share structure nearly identical to ours, what do you think will happen when news drops here???

1 · Reply

skyrockets_Inc Sep. 8 at 2:36 PM

$CYCN Two year chart shows how many times it's made these dips. Why would I be the chump who sells for a loss at these levels when it's clear its a temporary dip? Especially when CVCO news is due Oct 22 and TRD any day technically. Stop spreading FUD. Just move on w/ your loss if you aren't convinced about the future of CYCN. Unless you are trading on margin, no one gives a crap about temporary drops to $2. The investors here are long term holders who are waiting on news.

1 · Reply

BiotechValues Sep. 8 at 2:08 PM

$CYCN you were conned here folks. Certain accounts pumped non stop daily about 500% gains to try and lure you in, so they could dump on you. It's over...

1 · Reply

Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Aug 7, 2024, 7:00 AM EDT - 1 year ago

Regina Graul, Ph.D., Promoted to Chief Executive Officer

Dec 4, 2023, 8:00 AM EST - 1 year ago

Cyclerion Appoints Regina Graul, Ph.D., as President

Nov 30, 2023, 6:16 PM EST - 1 year ago

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

Jul 31, 2023, 7:00 AM EDT - 2 years ago

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets

Jun 1, 2023, 4:00 PM EDT - 2 years ago

Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement

May 15, 2023, 1:00 PM EDT - 2 years ago

Cyclerion Announces Reverse Stock Split

May 11, 2023, 6:00 PM EDT - 2 years ago

Cyclerion Announces Definitive Agreement for Zagociguat and CY3018

May 11, 2023, 6:00 PM EDT - 2 years ago

Cyclerion Announces Corporate Updates and Q1 2023 Financial Results

Apr 3, 2023, 7:30 AM EDT - 2 years ago

Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement

Mar 27, 2023, 7:00 AM EDT - 2 years ago

Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases

Mar 22, 2023, 4:40 PM EDT - 2 years ago

Cyclerion Reports Corporate Update and Full Year 2022 Financial Results

Nov 22, 2022, 7:00 AM EST - 3 years ago

Cyclerion Concludes Unsolicited Proposal Is Not in The Best Interest of The Company

Oct 6, 2022, 8:00 AM EDT - 3 years ago

Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy

Aug 9, 2022, 4:00 PM EDT - 3 years ago

Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results

Jul 28, 2022, 7:00 AM EDT - 3 years ago

Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in Patients with Cognitive Impairment Associated with Schizophrenia (CIAS)

Jul 26, 2022, 7:00 AM EDT - 3 years ago

Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics' Board of Directors

Jun 28, 2022, 9:00 AM EDT - 3 years ago

Cyclerion Therapeutics Provides Additional Positive CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation

Jun 22, 2022, 8:30 AM EDT - 3 years ago

Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation

Jun 17, 2022, 11:27 AM EDT - 3 years ago

Cyclerion Neurology Candidate Shows Encouraging Action In Preclinical Studies

Jun 17, 2022, 8:00 AM EDT - 3 years ago

Cyclerion Therapeutics Announces CY6463 Data Demonstrating Improved Cellular Energetics in Preclinical Models of Mitochondrial Disease

Jun 10, 2022, 7:00 AM EDT - 3 years ago

Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in MELAS Patients at UMDF Mitochondrial Medicine 2022 Symposium

Jun 6, 2022, 7:00 AM EDT - 3 years ago

Cyclerion Therapeutics to Share CY6463 MELAS Topline Study Results, CHOP to Present CY6463 Preclinical Data at UMDF Mitochondrial Medicine 2022 Symposium

May 4, 2022, 4:01 PM EDT - 3 years ago

Cyclerion Announces CY6463 Clinical Pipeline Progress and First Quarter 2022 Financial Results

Feb 24, 2022, 4:01 PM EST - 3 years ago

Cyclerion Announces CY6463 Clinical Pipeline and Corporate Updates

Feb 23, 2022, 8:00 AM EST - 3 years ago

Cyclerion Therapeutics and Ariana Pharma Announce an Artificial Intelligence-driven Precision Medicine Collaboration

Jan 26, 2022, 8:00 AM EST - 3 years ago

Cyclerion Therapeutics Announces Initiation of Patient Dosing in CY6463 Phase 2a Study in Alzheimer's Disease with Vascular Pathology

Nov 11, 2021, 5:32 PM EST - 4 years ago

Cyclerion Therapeutics to Participate in Jefferies London Healthcare Conference

Nov 9, 2021, 4:01 PM EST - 4 years ago

Cyclerion Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update

Oct 26, 2021, 4:29 PM EDT - 4 years ago

Cyclerion Therapeutics: Distressed Spinoff Developing New Medicines For CNS Disorders

Oct 20, 2021, 4:24 PM EDT - 4 years ago

Truist Bullish On This Clinical-Stage Biopharmaceutical Company With 374% Upside

Sep 22, 2021, 8:00 AM EDT - 4 years ago

Cyclerion Announces Publication of Preclinical Data Demonstrating Reduction in Neuroinflammation by Brain-Penetrant sGC Stimulator

Aug 23, 2021, 5:00 PM EDT - 4 years ago

Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer's Disease Summit

Jul 29, 2021, 5:00 PM EDT - 4 years ago

Cyclerion Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update

Jul 22, 2021, 4:30 PM EDT - 4 years ago

Cyclerion Therapeutics to Present Clinical Trial Design for CY6463 Phase 2a Study in Participants with Alzheimer's Disease with Vascular Pathology at the Alzheimer's Association International Conference 2021 (AAIC)

Jul 9, 2021, 6:14 AM EDT - 4 years ago

Cyclerion Recruits Beacon Biosignals To Identify Disease-Relevant EEG Neurological Biomarkers

Jul 8, 2021, 7:22 PM EDT - 4 years ago

Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership

Jul 8, 2021, 4:30 PM EDT - 4 years ago

Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership

Jun 4, 2021, 10:27 AM EDT - 4 years ago

Cyclerion Out-Licenses Praliciguat to Akebia, Announces $18M Capital Raise

AKBA

Jun 4, 2021, 8:00 AM EDT - 4 years ago

Cyclerion Therapeutics Announces Global Licensing Agreement with Akebia Therapeutics for Praliciguat

Jun 4, 2021, 8:00 AM EDT - 4 years ago

Cyclerion Therapeutics Announces $18 Million Private Placement

May 27, 2021, 4:30 PM EDT - 4 years ago

Cyclerion Therapeutics Announces Publication of CY6463 Preclinical Data in Frontiers in Pharmacology

May 25, 2021, 7:00 AM EDT - 4 years ago

Cyclerion Therapeutics to Participate in Jefferies Virtual Healthcare Conference

Apr 27, 2021, 12:03 PM EDT - 4 years ago

Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today

BNGO ALDX SLGL

Apr 27, 2021, 9:00 AM EDT - 4 years ago

Cyclerion Therapeutics Hosted Webinar to Discuss Pipeline Progress

Apr 26, 2021, 7:00 AM EDT - 4 years ago

Cyclerion Therapeutics Appoints Errol De Souza, Ph.D., to Board of Directors

Apr 21, 2021, 7:30 AM EDT - 4 years ago

Cyclerion Therapeutics to Participate in the B. Riley Neuroscience Investor Conference

Apr 20, 2021, 7:00 AM EDT - 4 years ago

Cyclerion Therapeutics to Host Pipeline Update Webinar

Mar 18, 2021, 5:00 PM EDT - 4 years ago

Cyclerion Therapeutics Announces Departure of Chief Medical Officer

Jan 25, 2021, 7:00 AM EST - 5 years ago

Cyclerion Therapeutics Announces Clinical and Scientific Advisory Boards

BiotechValues Sep. 9 at 4:17 PM

0 · Reply

SDBiotechInvestor Sep. 9 at 4:16 PM

$CYCN - too funny and embarrassing. Joel dumped $CYCN over the past week down to $2.10 only to REBUY the shares the next day after posting this.

0 · Reply

SDBiotechInvestor Sep. 9 at 4:12 PM

$CYCN outperforming all biotechs on my watchlist today. Long 35k shares :)

1 · Reply

BiotechValues Sep. 9 at 4:01 PM

1 · Reply

skyrockets_Inc Sep. 9 at 2:50 PM

$CYCN i made a hero trade yesterday, sold all of my $GLTO at $5 on that pump. Time to buy more $CYCN

0 · Reply

SDBiotechInvestor Sep. 9 at 1:31 PM

$CYCN - Going on a one-week trip starting tomorrow. If the universe plays out like it did for $GLTO (I was on a trip when they PR last year), we get a PR between September 10-17.

1 · Reply

skyrockets_Inc Sep. 8 at 8:05 PM

$CYCN All those scare tactics in the morning to drop it and then we end up closing green lol

1 · Reply

AshleySchaeffer_BMW Sep. 8 at 5:31 PM

$CYCN share structure nearly identical to ours, what do you think will happen when news drops here???

1 · Reply

skyrockets_Inc Sep. 8 at 2:36 PM

1 · Reply

BiotechValues Sep. 8 at 2:08 PM

$CYCN you were conned here folks. Certain accounts pumped non stop daily about 500% gains to try and lure you in, so they could dump on you. It's over...

1 · Reply

EZYME22 Sep. 7 at 1:32 PM

$CYCN Patent, Pascall, Masimo https://www.annualreviews.org/docserver/fulltext/neuro/48/1/annurev-neuro-112723-062031.pdf?expires=1757252543&id=id&accname=guest&checksum=98B49971B79115227FEFB984F2E9341C

1 · Reply

BigtradePT Sep. 7 at 8:55 AM

$CYCN Hard times are coming... Next week, it will fall below $2... By Christmas, it will be below $1... This company is just a scam, trying to take your money...

1 · Reply

AshleySchaeffer_BMW Sep. 5 at 7:29 PM

$CYCN it really is Christmas in September, these bear shorts giving the best of gifts!!!!

0 · Reply

BiotechValues Sep. 5 at 7:19 PM

$CYCN still have most of my shares to dump

0 · Reply

skyrockets_Inc Sep. 5 at 7:17 PM

$CYCN buying more. What a gift of a day. Thanks Joel and the other bashers . Santa Joel came early.

4 · Reply

KKEE122 Sep. 5 at 7:11 PM

$CYCN I am surprised by people who are losing money on the stock and are still optimistic about it. We will see a dollar while they sing about an empty company.

0 · Reply

SDBiotechInvestor Sep. 5 at 7:04 PM

$CYCN - Will nice to not have Joel not post on this board anymore given he dumped at the bottom.

1 · Reply

AshleySchaeffer_BMW Sep. 5 at 6:54 PM

$CYCN moved bid up, lets see if any takers...

0 · Reply

AshleySchaeffer_BMW Sep. 5 at 5:54 PM

$CYCN biggest shorturd in our high quality beloved Cyclerion just exited and the worst damage he could do is a -5% day, absolute and utter 👇👇👇👇👇👇👇

0 · Reply

SDBiotechInvestor Sep. 5 at 5:51 PM

$CYCN Looks like Joel officially dumped at the bottom folks! Too funny!

0 · Reply

KKEE122 Sep. 5 at 5:47 PM

$CYCN I got rid of half of the quantity at a price of 2.60, knowing that the average purchase was 2.80. I will get rid of the rest of the quantity with any rebound. I doubt that there is anyone in this company. Everyone has fled.

0 · Reply

BigtradePT Sep. 5 at 5:43 PM

$CYCN This is going to fall apart...get out while there's still time

0 · Reply

Market Cap	7.39M
Revenue (ttm)	2.00M
Net Income (ttm)	-3.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-153.00%
Debt to Equity Ratio	0.00

Volume	26,000
Avg Vol	42,536
Day's Range	N/A - N/A
Shares Out	3.34M
Stochastic %K	17%
Beta	1.34
Analysts	Strong Buy
Price Target	$4.00